|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-8-26
|
|
pubmed:abstractText |
There are increasing concerns about a possible association between anaplastic large cell lymphoma (ALCL) and breast implants. The authors conducted a structured expert consultation process to evaluate the evidence for the association, its clinical significance, and a potential biological model based on their interpretation of the published evidence.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1529-4242
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
128
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
629-39
|
|
pubmed:meshHeading |
pubmed-meshheading:21502904-Breast Implants,
pubmed-meshheading:21502904-Breast Neoplasms,
pubmed-meshheading:21502904-Causality,
pubmed-meshheading:21502904-Cross-Sectional Studies,
pubmed-meshheading:21502904-Female,
pubmed-meshheading:21502904-Humans,
pubmed-meshheading:21502904-Lymphoma, Large-Cell, Anaplastic,
pubmed-meshheading:21502904-Postoperative Complications,
pubmed-meshheading:21502904-Prognosis,
pubmed-meshheading:21502904-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:21502904-Referral and Consultation,
pubmed-meshheading:21502904-Reoperation,
pubmed-meshheading:21502904-Risk Factors,
pubmed-meshheading:21502904-Seroma,
pubmed-meshheading:21502904-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process.
|
|
pubmed:affiliation |
RAND Health and Pardee RAND Graduate School, RAND Corporation, Boston, MA 02116, USA.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
